Metabolic Instruction of Immunity

Cell

Volumn 169, Issue 4, 2017, Pages 570-586

  Buck, Michael D ^a,b   Sowell, Ryan T ^c   Kaech, Susan M ^c   Pearce, Erika L ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aerobic glycolysis; barrier immunity; checkpoint blockade; immunometabolism; immunotherapy; metabolism; mitochondria; mitochondrial dynamics; mucosa; tumor microenvironment

Indexed keywords

B LYMPHOCYTE; CANCER ASSOCIATED FIBROBLAST; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL METABOLISM; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT; ANIMAL; CYTOLOGY; GASTROINTESTINAL TRACT; IMMUNOLOGY; LEUKOCYTE; METABOLISM;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; LEUKOCYTES; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 85018769485     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2017.04.004     Document Type: Review

References (154)

1. Abbott, R.K., Thayer, M., Labuda, J., Silva, M., Philbrook, P., Cain, D.W., Kojima, H., Hatfield, S., Sethumadhavan, S., Ohta, A., et al. Germinal center hypoxia potentiates immunoglobulin class switch recombination. J. Immunol. 197 (2016), 4014–4020.
2. Adams, J.L., Smothers, J., Srinivasan, R., Hoos, A., Big opportunities for small molecules in immuno-oncology. Nat. Rev. Drug Discov. 14 (2015), 603–622.
3. Adams, W.C., Chen, Y.H., Kratchmarov, R., Yen, B., Nish, S.A., Lin, W.W., Rothman, N.J., Luchsinger, L.L., Klein, U., Busslinger, M., et al. Anabolism-associated mitochondrial stasis driving lymphocyte differentiation over self-renewal. Cell Rep. 17 (2016), 3142–3152.
4. Allen, B.G., Bhatia, S.K., Anderson, C.M., Eichenberger-Gilmore, J.M., Sibenaller, Z.A., Mapuskar, K.A., Schoenfeld, J.D., Buatti, J.M., Spitz, D.R., Fath, M.A., Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2 (2014), 963–970.
5. Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., Larsen, C.P., Ahmed, R., mTOR regulates memory CD8 T-cell differentiation. Nature 460 (2009), 108–112.
6. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., Rudensky, A.Y., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
7. Balmer, M.L., Ma, E.H., Bantug, G.R., Grählert, J., Pfister, S., Glatter, T., Jauch, A., Dimeloe, S., Slack, E., Dehio, P., et al. Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 44 (2016), 1312–1324.
8. Bengsch, B., Johnson, A.L., Kurachi, M., Odorizzi, P.M., Pauken, K.E., Attanasio, J., Stelekati, E., McLane, L.M., Paley, M.A., Delgoffe, G.M., Wherry, E.J., Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion. Immunity 45 (2016), 358–373.
9. Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C.N., Bähre, H., et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20 (2014), 1327–1333.
10. Brand, A., Singer, K., Koehl, G.E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24 (2016), 657–671.
11. Buck, M.D., O'Sullivan, D., Pearce, E.L., T cell metabolism drives immunity. J. Exp. Med. 212 (2015), 1345–1360.
12. Buck, M.D., O'Sullivan, D., Klein Geltink, R.I., Curtis, J.D., Chang, C.H., Sanin, D.E., Qiu, J., Kretz, O., Braas, D., van der Windt, G.J., et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166 (2016), 63–76.
13. Bustamante, E., Pedersen, P.L., High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. USA 74 (1977), 3735–3739.
14. Caro-Maldonado, A., Wang, R., Nichols, A.G., Kuraoka, M., Milasta, S., Sun, L.D., Gavin, A.L., Abel, E.D., Kelsoe, G., Green, D.R., Rathmell, J.C., Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192 (2014), 3626–3636.
15. Cham, C.M., Driessens, G., O'Keefe, J.P., Gajewski, T.F., Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur. J. Immunol. 38 (2008), 2438–2450.
16. Champagne, D.P., Hatle, K.M., Fortner, K.A., D'Alessandro, A., Thornton, T.M., Yang, R., Torralba, D., Tomás-Cortázar, J., Jun, Y.W., Ahn, K.H., et al. Fine-tuning of CD8(+) T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus. Immunity 44 (2016), 1299–1311.
17. Chang, C.H., Curtis, J.D., Maggi, L.B. Jr., Faubert, B., Villarino, A.V., O'Sullivan, D., Huang, S.C., van der Windt, G.J., Blagih, J., Qiu, J., et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153 (2013), 1239–1251.
18. Chang, C.H., Qiu, J., O'Sullivan, D., Buck, M.D., Noguchi, T., Curtis, J.D., Chen, Q., Gindin, M., Gubin, M.M., van der Windt, G.J., et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162 (2015), 1229–1241.
19. Cho, S.H., Raybuck, A.L., Stengel, K., Wei, M., Beck, T.C., Volanakis, E., Thomas, J.W., Hiebert, S., Haase, V.H., Boothby, M.R., Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature 537 (2016), 234–238.
20. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., Obin, M.S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46 (2005), 2347–2355.
21. Clever, D., Roychoudhuri, R., Constantinides, M.G., Askenase, M.H., Sukumar, M., Klebanoff, C.A., Eil, R.L., Hickman, H.D., Yu, Z., Pan, J.H., et al. Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell 166 (2016), 1117–1131.
22. Cogliati, S., Frezza, C., Soriano, M.E., Varanita, T., Quintana-Cabrera, R., Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L.C., et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell 155 (2013), 160–171.
23. Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Brokowski, C.E., Eisenbarth, S.C., Phillips, G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
24. Condamine, T., Dominguez, G.A., Youn, J.-I., Kossenkov, A.V., Mony, S., Alicea-Torres, K., Tcyganov, E., Hashimoto, A., Nefedova, Y., Lin, C., et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci. Immunol., 1, 2016, aaf8943.
25. Cubillos-Ruiz, J.R., Silberman, P.C., Rutkowski, M.R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S.E., Gupta, D., Holcomb, K., et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161 (2015), 1527–1538.
26. Cui, G., Staron, M.M., Gray, S.M., Ho, P.C., Amezquita, R.A., Wu, J., Kaech, S.M., IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell 161 (2015), 750–761.
27. Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.R., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146 (2011), 772–784.
28. De Rosa, V., Galgani, M., Porcellini, A., Colamatteo, A., Santopaolo, M., Zuchegna, C., Romano, A., De Simone, S., Procaccini, C., La Rocca, C., et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat. Immunol. 16 (2015), 1174–1184.
29. DeBerardinis, R.J., Chandel, N.S., Fundamentals of cancer metabolism. Sci. Adv., 2, 2016, e1600200.
30. Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B., Worley, P.F., Kozma, S.C., Powell, J.D., The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30 (2009), 832–844.
31. Doedens, A.L., Phan, A.T., Stradner, M.H., Fujimoto, J.K., Nguyen, J.V., Yang, E., Johnson, R.S., Goldrath, A.W., Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat. Immunol. 14 (2013), 1173–1182.
32. Doughty, C.A., Bleiman, B.F., Wagner, D.J., Dufort, F.J., Mataraza, J.M., Roberts, M.F., Chiles, T.C., Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107 (2006), 4458–4465.
33. Dufort, F.J., Bleiman, B.F., Gumina, M.R., Blair, D., Wagner, D.J., Roberts, M.F., Abu-Amer, Y., Chiles, T.C., Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J. Immunol. 179 (2007), 4953–4957.
34. Dufort, F.J., Gumina, M.R., Ta, N.L., Tao, Y., Heyse, S.A., Scott, D.A., Richardson, A.D., Seyfried, T.N., Chiles, T.C., Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J. Biol. Chem. 289 (2014), 7011–7024.
35. Eales, K.L., Hollinshead, K.E.R., Tennant, D.A., Hypoxia and metabolic adaptation of cancer cells. Oncogenesis, 5, 2016, e190.
36. Febbraio, M.A., Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol. Metab. 25 (2014), 312–319.
37. Finlay, D.K., Rosenzweig, E., Sinclair, L.V., Feijoo-Carnero, C., Hukelmann, J.L., Rolf, J., Panteleyev, A.A., Okkenhaug, K., Cantrell, D.A., PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209 (2012), 2441–2453.
38. Finucane, O.M., Lyons, C.L., Murphy, A.M., Reynolds, C.M., Klinger, R., Healy, N.P., Cooke, A.A., Coll, R.C., McAllan, L., Nilaweera, K.N., et al. Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity. Diabetes 64 (2015), 2116–2128.
39. Flint, T.R., Janowitz, T., Connell, C.M., Roberts, E.W., Denton, A.E., Coll, A.P., Jodrell, D.I., Fearon, D.T., Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity. Cell Metab. 24 (2016), 672–684.
40. Font-Burgada, J., Sun, B., Karin, M., Obesity and cancer: the oil that feeds the flame. Cell Metab. 23 (2016), 48–62.
41. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
42. Geiger, R., Rieckmann, J.C., Wolf, T., Basso, C., Feng, Y., Fuhrer, T., Kogadeeva, M., Picotti, P., Meissner, F., Mann, M., et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167 (2016), 829–842.e13.
43. Gerriets, V.A., Kishton, R.J., Johnson, M.O., Cohen, S., Siska, P.J., Nichols, A.G., Warmoes, M.O., de Cubas, A.A., MacIver, N.J., Locasale, J.W., et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat. Immunol. 17 (2016), 1459–1466.
44. Goveia, J., Stapor, P., Carmeliet, P., Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol. Med. 6 (2014), 1105–1120.
45. Gubser, P.M., Bantug, G.R., Razik, L., Fischer, M., Dimeloe, S., Hoenger, G., Durovic, B., Jauch, A., Hess, C., Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14 (2013), 1064–1072.
46. Guo, H., Callaway, J.B., Ting, J.P., Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21 (2015), 677–687.
47. Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D'Acquisto, F., Bland, E.J., Bombardieri, M., Pitzalis, C., Perretti, M., et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol., 13, 2015, e1002202.
48. Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.H., May, C., Wilck, N., et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43 (2015), 817–829.
49. Hand, T.W., Vujkovic-Cvijin, I., Ridaura, V.K., Belkaid, Y., Linking the microbiota, chronic disease, and the immune system. Trends Endocrinol. Metab. 27 (2016), 831–843.
50. Hatfield, S.M., Kjaergaard, J., Lukashev, D., Schreiber, T.H., Belikoff, B., Abbott, R., Sethumadhavan, S., Philbrook, P., Ko, K., Cannici, R., et al. Immunological mechanisms of the antitumor effects of supplemental oxygenation. Sci. Transl. Med., 7, 2015, 277ra230.
51. Hensley, C.T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. Metabolic heterogeneity in human lung tumors. Cell 164 (2016), 681–694.
52. Hernandez, A.L., Kitz, A., Wu, C., Lowther, D.E., Rodriguez, D.M., Vudattu, N., Deng, S., Herold, K.C., Kuchroo, V.K., Kleinewietfeld, M., Hafler, D.A., Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells. J. Clin. Invest. 125 (2015), 4212–4222.
53. Ho, P.-C., Bihuniak, J.D., Macintyre, A.N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.C., Cui, G., Micevic, G., Perales, J.C., et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162 (2015), 1217–1228.
54. Hotamisligil, G.S., Inflammation, metaflammation and immunometabolic disorders. Nature 542 (2017), 177–185.
55. Hsu, Y.-L., Hung, J.-Y., Chiang, S.-Y., Jian, S.-F., Wu, C.-Y., Lin, Y.-S., Tsai, Y.-M., Chou, S.-H., Tsai, M.-J., Kuo, P.-L., Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis. Oncotarget 7 (2016), 27584–27598.
56. Hu, H., Juvekar, A., Lyssiotis, C.A., Lien, E.C., Albeck, J.G., Oh, D., Varma, G., Hung, Y.P., Ullas, S., Lauring, J., et al. Phosphoinositide 3-kinase regulates glycolysis through mobilization of aldolase from the actin cytoskeleton. Cell 164 (2016), 433–446.
57. Jang, K.J., Mano, H., Aoki, K., Hayashi, T., Muto, A., Nambu, Y., Takahashi, K., Itoh, K., Taketani, S., Nutt, S.L., et al. Mitochondrial function provides instructive signals for activation-induced B-cell fates. Nat. Commun., 6, 2015, 6750.
58. Jellusova, J., Rickert, R.C., The PI3K pathway in B cell metabolism. Crit. Rev. Biochem. Mol. Biol. 51 (2016), 359–378.
59. Jellusova, J., Cato, M.H., Apgar, J.R., Ramezani-Rad, P., Leung, C.R., Chen, C., Richardson, A.D., Conner, E.M., Benschop, R.J., Woodgett, J.R., Rickert, R.C., Gsk3 is a metabolic checkpoint regulator in B cells. Nat. Immunol. 18 (2017), 303–312.
60. Jin, L., Alesi, G.N., Kang, S., Glutaminolysis as a target for cancer therapy. Oncogene 35 (2016), 3619–3625.
61. Johnston, R.J., Poholek, A.C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., Dent, A.L., Craft, J., Crotty, S., Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325 (2009), 1006–1010.
62. Kaiko, G.E., Ryu, S.H., Koues, O.I., Collins, P.L., Solnica-Krezel, L., Pearce, E.J., Pearce, E.L., Oltz, E.M., Stappenbeck, T.S., The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 165 (2016), 1708–1720.
63. Kaplan, M.H., Hufford, M.M., Olson, M.R., The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15 (2015), 295–307.
64. Kawalekar, O.U., O'Connor, R.S., Fraietta, J.A., Guo, L., McGettigan, S.E., Posey, A.D. Jr., Patel, P.R., Guedan, S., Scholler, J., Keith, B., et al. Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells. Immunity 44 (2016), 380–390.
65. Keating, R., Hertz, T., Wehenkel, M., Harris, T.L., Edwards, B.A., McClaren, J.L., Brown, S.A., Surman, S., Wilson, Z.S., Bradley, P., et al. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat. Immunol. 14 (2013), 1266–1276.
66. Kim, M., Qie, Y., Park, J., Kim, C.H., Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20 (2016), 202–214.
67. Kleffel, S., Posch, C., Barthel, S.R., Mueller, H., Schlapbach, C., Guenova, E., Elco, C.P., Lee, N., Juneja, V.R., Zhan, Q., et al. Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell 162 (2015), 1242–1256.
68. Kopf, H., de la Rosa, G.M., Howard, O.M., Chen, X., Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int. Immunopharmacol. 7 (2007), 1819–1824.
69. Krawczyk, C.M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R.J., Cross, J.R., Jung, E., Thompson, C.B., Jones, R.G., Pearce, E.J., Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115 (2010), 4742–4749.
70. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., Müller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993), 263–274.
71. Kunisawa, J., Sugiura, Y., Wake, T., Nagatake, T., Suzuki, H., Nagasawa, R., Shikata, S., Honda, K., Hashimoto, E., Suzuki, Y., et al. Mode of bioenergetic metabolism during B cell differentiation in the intestine determines the distinct requirement for vitamin B1. Cell Rep. 13 (2015), 122–131.
72. Kurashima, Y., Kiyono, H., Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing. Annu. Rev. Immunol., 2017, 10.1146/annurev-immunol-051116-052424.
73. Laidlaw, B.J., Cui, W., Amezquita, R.A., Gray, S.M., Guan, T., Lu, Y., Kobayashi, Y., Flavell, R.A., Kleinstein, S.H., Craft, J., Kaech, S.M., Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells. Nat. Immunol. 16 (2015), 871–879.
74. Lam, W.Y., Becker, A.M., Kennerly, K.M., Wong, R., Curtis, J.D., Llufrio, E.M., McCommis, K.S., Fahrmann, J., Pizzato, H.A., Nunley, R.M., et al. Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity 45 (2016), 60–73.
75. Lee, G.K., Park, H.J., Macleod, M., Chandler, P., Munn, D.H., Mellor, A.L., Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107 (2002), 452–460.
76. Lee, K., Heffington, L., Jellusova, J., Nam, K.T., Raybuck, A., Cho, S.H., Thomas, J.W., Rickert, R.C., Boothby, M., Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 122 (2013), 2369–2379.
77. Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., Park, J.-W., Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol. Cell 38 (2010), 864–878.
78. Liu, G., Bi, Y., Shen, B., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Liao, J., Chen, X., Chu, Y., SIRT1 limits the function and fate of myeloid-derived suppressor cells in tumors by orchestrating HIF-1α-dependent glycolysis. Cancer Res. 74 (2014), 727–737.
79. Ma, E.H., Bantug, G., Griss, T., Condotta, S., Johnson, R.M., Samborska, B., Mainolfi, N., Suri, V., Guak, H., Balmer, M.L., et al. Serine is an essential metabolite for effector T cell expansion. Cell Metab. 25 (2017), 345–357.
80. Macintyre, A.N., Gerriets, V.A., Nichols, A.G., Michalek, R.D., Rudolph, M.C., Deoliveira, D., Anderson, S.M., Abel, E.D., Chen, B.J., Hale, L.P., Rathmell, J.C., The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20 (2014), 61–72.
81. MacIver, N.J., Michalek, R.D., Rathmell, J.C., Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31 (2013), 259–283.
82. Man, K., Kutyavin, V.I., Chawla, A., Tissue immunometabolism: development, physiology, and pathobiology. Cell Metab. 25 (2017), 11–26.
83. McLaughlin, T., Ackerman, S.E., Shen, L., Engleman, E., Role of innate and adaptive immunity in obesity-associated metabolic disease. J. Clin. Invest. 127 (2017), 5–13.
84. Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Macintyre, A.N., MacIver, N.J., Mason, E.F., Sullivan, S.A., Nichols, A.G., Rathmell, J.C., Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186 (2011), 3299–3303.
85. Milasta, S., Dillon, C.P., Sturm, O.E., Verbist, K.C., Brewer, T.L., Quarato, G., Brown, S.A., Frase, S., Janke, L.J., Perry, S.S., et al. Apoptosis-inducing-factor-dependent mitochondrial function is required for T cell but not B cell function. Immunity 44 (2016), 88–102.
86. Monticelli, L.A., Buck, M.D., Flamar, A.L., Saenz, S.A., Tait Wojno, E.D., Yudanin, N.A., Osborne, L.C., Hepworth, M.R., Tran, S.V., Rodewald, H.R., et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat. Immunol. 17 (2016), 656–665.
87. Moon, J.-S., Nakahira, K., Chung, K.-P., DeNicola, G.M., Koo, M.J., Pabón, M.A., Rooney, K.T., Yoon, J.-H., Ryter, S.W., Stout-Delgado, H., Choi, A.M., NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat. Med. 22 (2016), 1002–1012.
88. Munn, D.H., Sharma, M.D., Lee, J.R., Jhaver, K.G., Johnson, T.S., Keskin, D.B., Marshall, B., Chandler, P., Antonia, S.J., Burgess, R., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002), 1867–1870.
89. Newton, R., Priyadharshini, B., Turka, L.A., Immunometabolism of regulatory T cells. Nat. Immunol. 17 (2016), 618–625.
90. Nieman, K.M., Kenny, H.A., Penicka, C.V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M.R., Romero, I.L., Carey, M.S., Mills, G.B., Hotamisligil, G.S., et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17 (2011), 1498–1503.
91. Noman, M.Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., Chouaib, S., PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J. Exp. Med. 211 (2014), 781–790.
92. Nurieva, R.I., Chung, Y., Martinez, G.J., Yang, X.O., Tanaka, S., Matskevitch, T.D., Wang, Y.H., Dong, C., Bcl6 mediates the development of T follicular helper cells. Science 325 (2009), 1001–1005.
93. O'Neill, L.A., Pearce, E.J., Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213 (2016), 15–23.
94. O'Neill, L.A.J., Kishton, R.J., Rathmell, J., A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16 (2016), 553–565.
95. O'Sullivan, D., van der Windt, G.J., Huang, S.C., Curtis, J.D., Chang, C.H., Buck, M.D., Qiu, J., Smith, A.M., Lam, W.Y., DiPlato, L.M., et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41 (2014), 75–88.
96. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A.W., Chawla, A., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 (2007), 1116–1120.
97. Oestreich, K.J., Read, K.A., Gilbertson, S.E., Hough, K.P., McDonald, P.W., Krishnamoorthy, V., Weinmann, A.S., Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 15 (2014), 957–964.
98. Pan, Y., Tian, T., Park, C.O., Lofftus, S.Y., Mei, S., Liu, X., Luo, C., O'Malley, J.T., Gehad, A., Teague, J.E., et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543 (2017), 252–256.
99. Park, E.J., Lee, J.H., Yu, G.Y., He, G., Ali, S.R., Holzer, R.G., Osterreicher, C.H., Takahashi, H., Karin, M., Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140 (2010), 197–208.
100. Parry, R.V., Chemnitz, J.M., Frauwirth, K.A., Lanfranco, A.R., Braunstein, I., Kobayashi, S.V., Linsley, P.S., Thompson, C.B., Riley, J.L., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25 (2005), 9543–9553.
101. Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L.N., Karoly, E.D., Freeman, G.J., Petkova, V., Seth, P., et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat. Commun., 6, 2015, 6692.
102. Pearce, E.L., Walsh, M.C., Cejas, P.J., Harms, G.M., Shen, H., Wang, L.S., Jones, R.G., Choi, Y., Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460 (2009), 103–107.
103. Pearce, E.L., Poffenberger, M.C., Chang, C.H., Jones, R.G., Fueling immunity: insights into metabolism and lymphocyte function. Science, 342, 2013, 1242454.
104. Peng, M., Yin, N., Chhangawala, S., Xu, K., Leslie, C.S., Li, M.O., Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354 (2016), 481–484.
105. Pérez-Escuredo, J., Dadhich, R.K., Dhup, S., Cacace, A., Van Hée, V.F., De Saedeleer, C.J., Sboarina, M., Rodriguez, F., Fontenille, M.-J., Brisson, L., et al. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15 (2016), 72–83.
106. Phan, A.T., Doedens, A.L., Palazon, A., Tyrakis, P.A., Cheung, K.P., Johnson, R.S., Goldrath, A.W., Constitutive glycolytic metabolism supports CD8(+) T cell effector memory differentiation during viral infection. Immunity 45 (2016), 1024–1037.
107. Pollizzi, K.N., Sun, I.-H., Patel, C.H., Lo, Y.-C., Oh, M.-H., Waickman, A.T., Tam, A.J., Blosser, R.L., Wen, J., Delgoffe, G.M., Powell, J.D., Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation. Nat. Immunol. 17 (2016), 704–711.
108. Porporato, P.E., Understanding cachexia as a cancer metabolism syndrome. Oncogenesis, 5, 2016, e200.
109. Ramakrishnan, R., Tyurin, V.A., Veglia, F., Condamine, T., Amoscato, A., Mohammadyani, D., Johnson, J.J., Zhang, L.M., Klein-Seetharaman, J., Celis, E., et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J. Immunol. 192 (2014), 2920–2931.
110. Rao, S., Schieber, A.M., O'Connor, C.P., Leblanc, M., Michel, D., Ayres, J.S., Pathogen-mediated inhibition of anorexia promotes host survival and transmission. Cell 168 (2017), 503–516.
111. Rathinam, V.A., Fitzgerald, K.A., Inflammasome complexes: emerging mechanisms and effector functions. Cell 165 (2016), 792–800.
112. Ray, J.P., Staron, M.M., Shyer, J.A., Ho, P.C., Marshall, H.D., Gray, S.M., Laidlaw, B.J., Araki, K., Ahmed, R., Kaech, S.M., Craft, J., The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T helper 1 and follicular B helper T cells. Immunity 43 (2015), 690–702.
113. Reboldi, A., Cyster, J.G., Peyer's patches: organizing B-cell responses at the intestinal frontier. Immunol. Rev. 271 (2016), 230–245.
114. Ribas, A., Releasing the brakes on cancer immunotherapy. N. Engl. J. Med. 373 (2015), 1490–1492.
115. Rodriguez, P.C., Quiceno, D.G., Zabaleta, J., Ortiz, B., Zea, A.H., Piazuelo, M.B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E.M., et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64 (2004), 5839–5849.
116. Ron-Harel, N., Santos, D., Ghergurovich, J.M., Sage, P.T., Reddy, A., Lovitch, S.B., Dephoure, N., Satterstrom, F.K., Sheffer, M., Spinelli, J.B., et al. Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation. Cell Metab. 24 (2016), 104–117.
117. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352.
118. Saltiel, A.R., Olefsky, J.M., Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest. 127 (2017), 1–4.
119. Scharping, N.E., Menk, A.V., Moreci, R.S., Whetstone, R.D., Dadey, R.E., Watkins, S.C., Ferris, R.L., Delgoffe, G.M., The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity 45 (2016), 374–388.
120. Scharping, N.E., Menk, A.V., Whetstone, R.D., Zeng, X., Delgoffe, G.M., Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol. Res. 5 (2017), 9–16.
121. Schultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W., Laudes, M., Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS ONE, 5, 2010, e14328.
122. Sena, L.A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D.A., Wang, C.R., Schumacker, P.T., Licht, J.D., Perlman, H., et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38 (2013), 225–236.
123. Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R., Chi, H., HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208 (2011), 1367–1376.
124. Shouval, D.S., Biswas, A., Goettel, J.A., McCann, K., Conaway, E., Redhu, N.S., Mascanfroni, I.D., Al Adham, Z., Lavoie, S., Ibourk, M., et al. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 40 (2014), 706–719.
125. Sinclair, L.V., Rolf, J., Emslie, E., Shi, Y.B., Taylor, P.M., Cantrell, D.A., Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 14 (2013), 500–508.
126. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 (2013), 569–573.
127. Sonveaux, P., Végran, F., Schroeder, T., Wergin, M.C., Verrax, J., Rabbani, Z.N., De Saedeleer, C.J., Kennedy, K.M., Diepart, C., Jordan, B.F., et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118 (2008), 3930–3942.
128. Spencer, S.D., Di Marco, F., Hooley, J., Pitts-Meek, S., Bauer, M., Ryan, A.M., Sordat, B., Gibbs, V.C., Aguet, M., The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187 (1998), 571–578.
129. Staron, M.M., Gray, S.M., Marshall, H.D., Parish, I.A., Chen, J.H., Perry, C.J., Cui, G., Li, M.O., Kaech, S.M., The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection. Immunity 41 (2014), 802–814.
130. Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J.G., Yu, Z., Roychoudhuri, R., Palmer, D.C., Muranski, P., Karoly, E.D., et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 123 (2013), 4479–4488.
131. Swamy, M., Pathak, S., Grzes, K.M., Damerow, S., Sinclair, L.V., van Aalten, D.M.F., Cantrell, D.A., Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat. Immunol. 17 (2016), 712–720.
132. Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., Akira, S., Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999), 39–49.
133. Torres, A., Luke, J.D., Kullas, A.L., Kapilashrami, K., Botbol, Y., Koller, A., Tonge, P.J., Chen, E.I., Macian, F., van der Velden, A.W., Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming. J. Leukoc. Biol. 99 (2016), 387–398.
134. Tyrakis, P.A., Palazon, A., Macias, D., Lee, K.L., Phan, A.T., Veliça, P., You, J., Chia, G.S., Sim, J., Doedens, A., et al. S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate. Nature 540 (2016), 236–241.
135. Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., Van den Eynde, B.J., Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat. Med. 9 (2003), 1269–1274.
136. van der Windt, G.J., Everts, B., Chang, C.H., Curtis, J.D., Freitas, T.C., Amiel, E., Pearce, E.J., Pearce, E.L., Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36 (2012), 68–78.
137. Verbist, K.C., Guy, C.S., Milasta, S., Liedmann, S., Kamiński, M.M., Wang, R., Green, D.R., Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature 532 (2016), 389–393.
138. Vesely, M.D., Schreiber, R.D., Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann. N Y Acad. Sci. 1284 (2013), 1–5.
139. Vuillefroy de Silly, R., Dietrich, P.-Y., Walker, P.R., Hypoxia and antitumor CD8(+) T cells: An incompatible alliance?. OncoImmunology, 5, 2016, e1232236.
140. Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L.L., Fitzgerald, P., Chi, H., Munger, J., Green, D.R., The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35 (2011), 871–882.
141. Wang, C., Yosef, N., Gaublomme, J., Wu, C., Lee, Y., Clish, C.B., Kaminski, J., Xiao, S., Meyer Zu Horste, G., Pawlak, M., et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell 163 (2015), 1413–1427.
142. Wang, A., Huen, S.C., Luan, H.H., Yu, S., Zhang, C., Gallezot, J.D., Booth, C.J., Medzhitov, R., Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell 166 (2016), 1512–1525.
143. Wang, Y., Bi, Y., Chen, X., Li, C., Li, Y., Zhang, Z., Wang, J., Lu, Y., Yu, Q., Su, H., et al. Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4(+) T cells. Immunity 44 (2016), 1337–1349.
144. Wegrzyn, J., Potla, R., Chwae, Y.J., Sepuri, N.B., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. Function of mitochondrial Stat3 in cellular respiration. Science 323 (2009), 793–797.
145. Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martín-Pérez, R., Serneels, J., Prenen, H., Ghesquière, B., Carmeliet, P., Mazzone, M., Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab. 24 (2016), 701–715.
146. Wherry, E.J., Kurachi, M., Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15 (2015), 486–499.
147. Wilhelm, C., Harrison, O.J., Schmitt, V., Pelletier, M., Spencer, S.P., Urban, J.F. Jr., Ploch, M., Ramalingam, T.R., Siegel, R.M., Belkaid, Y., Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213 (2016), 1409–1418.
148. Woodland, R.T., Fox, C.J., Schmidt, M.R., Hammerman, P.S., Opferman, J.T., Korsmeyer, S.J., Hilbert, D.M., Thompson, C.B., Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111 (2008), 750–760.
149. Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature 531 (2016), 651–655.
150. Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
151. Zeng, H., Cohen, S., Guy, C., Shrestha, S., Neale, G., Brown, S.A., Cloer, C., Kishton, R.J., Gao, X., Youngblood, B., et al. mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity 45 (2016), 540–554.
152. Zhao, E., Maj, T., Kryczek, I., Li, W., Wu, K., Zhao, L., Wei, S., Crespo, J., Wan, S., Vatan, L., et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat. Immunol. 17 (2016), 95–103.
153. Zhou, X., Yu, S., Zhao, D.M., Harty, J.T., Badovinac, V.P., Xue, H.H., Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity 33 (2010), 229–240.
154. Zigmond, E., Bernshtein, B., Friedlander, G., Walker, C.R., Yona, S., Kim, K.W., Brenner, O., Krauthgamer, R., Varol, C., Müller, W., Jung, S., Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40 (2014), 720–733.